Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

OBJECTIVE: To verify the hypothesis that in rheumatoid arthritis (RA), tumor necrosis factor alpha (TNFalpha) plays a critical role in regulating leukocyte trafficking and chemokine levels. METHODS: Ten patients with longstanding RA received a single 10 mg/kg infusion of anti-TNFalpha monoclonal ant...

Podrobná bibliografie
Hlavní autoři:	Taylor, P, Peters, A, Paleolog, E, Chapman, P, Elliott, M, McCloskey, R, Feldmann, M, Maini, R
Médium:	Journal article
Jazyk:	English
Vydáno:	2000

Podobné jednotky

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Autor: Paleolog, E, a další
Vydáno: (1998)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
Autor: Maini, R, a další
Vydáno: (1995)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
Autor: Davis, D, a další
Vydáno: (1997)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
Autor: Feldmann, M, a další
Vydáno: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
Autor: Paleolog, E, a další
Vydáno: (1996)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
Autor: Taylor, P, a další
Vydáno: (2001)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1997)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
Autor: Elliott, M, a další
Vydáno: (1995)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
Autor: Brennan, F, a další
Vydáno: (1995)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
Autor: Taylor, P, a další
Vydáno: (1999)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
Autor: Maini, R, a další
Vydáno: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Autor: Elliott, M, a další
Vydáno: (1993)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
Autor: Maini, R, a další
Vydáno: (1997)

Cytokine blockade in rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (2001)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
Autor: Elliott, M, a další
Vydáno: (1995)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
Autor: Maini, R, a další
Vydáno: (1998)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1994)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
Autor: Elliott, M, a další
Vydáno: (1994)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
Autor: Maini, R, a další
Vydáno: (1999)

TNF alpha as a therapeutic target in rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1994)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
Autor: Chu, C, a další
Vydáno: (1991)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Autor: Elliot, M, a další
Vydáno: (2008)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
Autor: Maini, R, a další
Vydáno: (1994)

Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.
Autor: Schmidt, E, a další
Vydáno: (2013)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1995)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
Autor: Haworth, C, a další
Vydáno: (1991)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
Autor: Ulfgren, A, a další
Vydáno: (2000)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
Autor: Maini, R, a další
Vydáno: (1995)

TNF alpha--a pivotal role in rheumatoid arthritis?
Autor: Brennan, F, a další
Vydáno: (1992)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
Autor: Williams, R, a další
Vydáno: (2000)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
Autor: Buchan, G, a další
Vydáno: (1988)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
Autor: Feldmann, M
Vydáno: (1996)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
Autor: Deleuran, B, a další
Vydáno: (1992)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Autor: Feldmann, M, a další
Vydáno: (2001)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (2001)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
Autor: Feldmann, M, a další
Vydáno: (2002)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Autor: Maini, R, a další
Vydáno: (1993)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
Autor: Elliott, M, a další
Vydáno: (1994)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
Autor: Brennan, F, a další
Vydáno: (1997)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
Autor: Feldmann, M, a další
Vydáno: (1995)